Vulvar/Vaginal Melanoma An Updated Surveillance Epidemiology and End Results Database Review, Comparison With Cutaneous Melanoma and Significance of Racial Disparities

被引:42
作者
Mert, Ismail [1 ]
Semaan, Assaad [1 ]
Winer, Ira [1 ]
Morris, Robert T. [1 ]
Ali-Fehmi, Rouba [2 ]
机构
[1] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA
[2] Wayne State Univ, Dept Pathol, Detroit, MI 48201 USA
关键词
Vulvar/Vaginal melanoma; Cutaneous melanoma; SEER; Racial disparity; MALIGNANT-MELANOMA; VULVAR MELANOMA; UNITED-STATES; NODE BIOPSY; CANCER; VAGINA; RISK; RADIOTHERAPY; SURVIVAL; TRENDS;
D O I
10.1097/IGC.0b013e3182980ffb
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: We aimed to compare the differences in demographic features, clinicopathologic features, and survival in patients with vulvar/vaginal melanoma versus cutaneous melanoma with a special emphasis on race. Materials and Methods: Data were obtained from the Surveillance Epidemiology and End Results database from 1973 to 2008. Kaplan-Meier curves and Cox multivariate model were used for statistical analysis. Results: Seven hundred sixty-two patients with vulvar/vaginal melanoma and 55,485 patients with cutaneous melanoma patients were included in the study. Twenty-eight patients of the vulvar/vaginal group and 334 patients of the cutaneous group were black (3.6% vs 0.6%, respectively). The median age at the time of diagnosis was 68 years in the vulvar/vaginal group and 52 years in the cutaneous group (P < 0.0001). Three hundred fifty patients (45.9%) in the vulvar/vaginal and 46,499 patients (83.8%) in the cutaneous group presented with localized disease (P < 0.0001), whereas 64 patients (8.4%) in the vulvar/vaginal group and 1520 patients (2.7%) in cutaneous group presented with advanced disease (P = 0.0081). The median survival of the black patients was 16 months in the vulvar/vaginal group and 124 months in the cutaneous melanoma group (P < 0.0001). The median survival in the nonblack population was 39 months in the vulvar/vaginal group compared to 319 months in the cutaneous melanoma group (P <0.0001). In multivariate analysis performed for patients between 1988 and 2008, age, stage, and positive lymph nodes were negative independent prognostic factors for survival in vulvar/vaginal melanoma; whereas age, race, stage, radiation therapy, and lymph node positivity were negative prognostic factors in cutaneous melanoma. Conclusion: These findings emphasize that cutaneous and vulvar/vaginal melanomas have different clinicopathologic features and survival patterns.
引用
收藏
页码:1118 / 1125
页数:8
相关论文
共 32 条
[1]   Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial [J].
Burmeister, Bryan H. ;
Henderson, Michael A. ;
Ainslie, Jill ;
Fisher, Richard ;
Di Iulio, Juliana ;
Smithers, B. Mark ;
Hong, Angela ;
Shannon, Kerwin ;
Scolyer, Richard A. ;
Carruthers, Scott ;
Coventry, Brendon J. ;
Babington, Scott ;
Duprat, Joao ;
Hoekstra, Harald J. ;
Thompson, John F. .
LANCET ONCOLOGY, 2012, 13 (06) :589-597
[2]   Surgical margins for resection of primary cutaneous melanoma [J].
Cook, J .
CLINICS IN DERMATOLOGY, 2004, 22 (03) :228-233
[3]  
Creasman WT, 1998, CANCER, V83, P1033, DOI 10.1002/(SICI)1097-0142(19980901)83:5<1033::AID-CNCR30>3.3.CO
[4]  
2-T
[5]   Vulvar melanoma - Is there a role for sentinel lymph node biopsy? [J].
de Hullu, JA ;
Hollema, H ;
Hoekstra, HJ ;
Piers, DA ;
Mourits, MJE ;
Aalders, JG ;
van der Zee, AGJ .
CANCER, 2002, 94 (02) :486-491
[6]   Tanning beds, sunlamps, and risk of cutaneous malignant melanoma [J].
Gallagher, RP ;
Spinelli, JJ ;
Lee, TK .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (03) :562-566
[7]  
HALDER RM, 1995, CANCER, V75, P667, DOI 10.1002/1097-0142(19950115)75:2+<667::AID-CNCR2820751409>3.0.CO
[8]  
2-I
[9]   Update on the incidence and mortality from melanoma in the United States [J].
Hall, HI ;
Miller, DR ;
Rogers, JD ;
Bewerse, B .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (01) :35-42
[10]  
Kim Christina J, 2002, Cancer Control, V9, P9